Lele Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Signal transduction and targeted therapy

PLoS pathogens

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

Institute of Biochemistry and Cell Biology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Institute of Biochemistry and Cell Biology Sep 01 2014 - Jun 30 2019

China

PHD

Jilin University Sep 01 2010 - Jul 01 2014

China

BSC

Publications

Haoran Xia, Han Zhang, Zheng Ruan, Huibiao Zhang, Liangdong Sun, Hezhong Chen, Yongxin Zhou, Lele Zhang, Dongliang Bian, Xinsheng Zhu, Jing Zhang, Fenghuan Sun, Huansha Yu, Nan Song, Xiaogang Liu, Yuming Zhu, Haiping Zhang, Wenxin He, Jian Chen, Jie Yang, Guohan Chen, Shiliang Xie, Dongfang Tang, Xiaomiao Zhang, Liang Duan, Deping Zhao, Qinchuan Li, Peng Zhang, Gening Jiang
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study. Signal transduction and targeted therapy 9 (1) (2024)
Haoran Xia, Han Zhang, Zheng Ruan, Huibiao Zhang, Liangdong Sun, Hezhong Chen, Yongxin Zhou, Lele Zhang, Dongliang Bian, Xinsheng Zhu, Jing Zhang, Fenghuan Sun, Huansha Yu, Nan Song, Xiaogang Liu, Yuming Zhu, Haiping Zhang, Wenxin He, Jian Chen, Jie Yang, Guohan Chen, Shiliang Xie, Dongfang Tang, Xiaomiao Zhang, Liang Duan, Deping Zhao, Qinchuan Li, Peng Zhang, Gening Jiang
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study. Signal transduction and targeted therapy 9 (1) (2024)
Haoran Xia, Han Zhang, Zheng Ruan, Huibiao Zhang, Liangdong Sun, Hezhong Chen, Yongxin Zhou, Lele Zhang, Dongliang Bian, Xinsheng Zhu, Jing Zhang, Fenghuan Sun, Huansha Yu, Nan Song, Xiaogang Liu, Yuming Zhu, Haiping Zhang, Wenxin He, Jian Chen, Jie Yang, Guohan Chen, Shiliang Xie, Dongfang Tang, Xiaomiao Zhang, Liang Duan, Deping Zhao, Qinchuan Li, Peng Zhang, Gening Jiang
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study. Signal transduction and targeted therapy 9 (1) (2024)
Haoran Xia, Han Zhang, Zheng Ruan, Huibiao Zhang, Liangdong Sun, Hezhong Chen, Yongxin Zhou, Lele Zhang, Dongliang Bian, Xinsheng Zhu, Jing Zhang, Fenghuan Sun, Huansha Yu, Nan Song, Xiaogang Liu, Yuming Zhu, Haiping Zhang, Wenxin He, Jian Chen, Jie Yang, Guohan Chen, Shiliang Xie, Dongfang Tang, Xiaomiao Zhang, Liang Duan, Deping Zhao, Qinchuan Li, Peng Zhang, Gening Jiang
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study. Signal transduction and targeted therapy 9 (1) (2024)
Dongliang Bian, Liangdong Sun, Junjie Hu, Liang Duan, Haoran Xia, Xinsheng Zhu, Fenghuan Sun, Lele Zhang, Huansha Yu, Yicheng Xiong, Zhida Huang, Deping Zhao, Nan Song, Jie Yang, Xiao Bao, Wei Wu, Jie Huang, Wenxin He, Yuming Zhu, Gening Jiang, Peng Zhang
Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study. Nature communications 14 (1) (2023)
Qiangsheng Hu, Jie Dai, Zheng Zhang, Huansha Yu, Jing Zhang, Xinsheng Zhu, Yi Qin, Lele Zhang, Peng Zhang
ASS1-mediated reductive carboxylation of cytosolic glutamine confers ferroptosis resistance in cancer cells. Cancer research (2023)
Ze Hong, Jiahao Mei, Chenhui Li, Guohui Bai, Munire Maimaiti, Haiyang Hu, Wenying Yu, Li Sun, Lele Zhang, Dan Cheng, Yixian Liao, Senlin Li, Yanping You, Hongbin Sun, Jing Huang, Xing Liu, Judy Lieberman, Chen Wang
STING inhibitors target the cyclic dinucleotide binding pocket. Proceedings of the National Academy of Sciences of the United States of America 118 (24) (2021)
Chenhui Li, Lele Zhang, Dong Qian, Mingxing Cheng, Haiyang Hu, Ze Hong, Ye Cui, Huansha Yu, Quanyi Wang, Juanjuan Zhu, Wei Meng, Jin-Fu Xu, Yi Sun, Peng Zhang, Chen Wang
RNF111-facilitated neddylation potentiates cGAS-mediated antiviral innate immune response. PLoS pathogens 17 (3) (2021)
Mingyu Pan, Yue Yin, Xinxia Wang, Quanyi Wang, Lele Zhang, Haiyang Hu, Chen Wang
Mice deficient in UXT exhibit retinitis pigmentosa-like features via aberrant autophagy activation. Autophagy 17 (8) (2020)
Boyue Sun, Haoyang Zeng, Jiaqian Liang, Lele Zhang, Haiyang Hu, Quanyi Wang, Wei Meng, Chenhui Li, Fuqiang Ye, Chen Wang, Juanjuan Zhu
NSUN5 Facilitates Viral RNA Recognition by RIG-I Receptor. Journal of immunology (Baltimore, Md. : 1950) 205 (12) (2020)

Lele Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lele Zhang